New Data Reinforce Benefits of TomoTherapy(R) Platform for Mainstream Radiation Therapy Treatment Indications

Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control withReduced Toxicities SUNNYVALE, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies contin... Devices, Oncology Accuray, TomoTherapy, radiotherapy, IMRT
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news